| Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data P Sasieni, A Castanon, J Cuzick Bmj 339, 2009 | 489 | 2009 |
| The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based … M Falcaro, A Castañon, B Ndlela, M Checchi, K Soldan, J Lopez-Bernal, ... The Lancet 398 (10316), 2084-2092, 2021 | 339 | 2021 |
| Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case–control study R Landy, F Pesola, A Castañón, P Sasieni British journal of cancer 115 (9), 1140-1146, 2016 | 325 | 2016 |
| Screening and adenocarcinoma of the cervix P Sasieni, A Castanon, J Cuzick International journal of cancer 125 (3), 525-529, 2009 | 168 | 2009 |
| Risk of preterm birth after treatment for cervical intraepithelial neoplasia among women attending colposcopy in England: retrospective-prospective cohort study A Castanon, P Brocklehurst, H Evans, D Peebles, N Singh, P Walker, ... Bmj 345, 2012 | 148 | 2012 |
| Cervical screening at age 50–64 years and the risk of cervical cancer at age 65 years and older: population-based case control study A Castanon, R Landy, J Cuzick, P Sasieni PLoS medicine 11 (1), e1001585, 2014 | 137 | 2014 |
| Risk of preterm delivery with increasing depth of excision for cervical intraepithelial neoplasia in England: nested case-control study A Castanon, R Landy, P Brocklehurst, H Evans, D Peebles, N Singh, ... Bmj 349, 2014 | 133 | 2014 |
| Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20–29 in the UK J Cuzick, A Castanon, P Sasieni British journal of cancer 102 (5), 933-939, 2010 | 106 | 2010 |
| Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix? A Castanon, R Landy, PD Sasieni International journal of cancer 139 (5), 1040-1045, 2016 | 105 | 2016 |
| Head-to-head comparison of the RNA-based aptima human papillomavirus (HPV) assay and the DNA-based hybrid capture 2 HPV test in a routine screening population of women aged 30 … T Iftner, S Becker, KJ Neis, A Castanon, A Iftner, B Holz, A Staebler, ... Journal of clinical microbiology 53 (8), 2509-2516, 2015 | 99 | 2015 |
| HPV16 L1 and L2 DNA methylation predicts high‐grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology AT Lorincz, AR Brentnall, N Vasiljević, D Scibior‐Bentkowska, ... International journal of cancer 133 (3), 637-644, 2013 | 69 | 2013 |
| Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study A Castanon, R Landy, F Pesola, P Windridge, P Sasieni The Lancet Public Health 3 (1), e34-e43, 2018 | 61 | 2018 |
| Characteristics and screening history of women diagnosed with cervical cancer aged 20–29 years A Castanon, VMW Leung, R Landy, AWW Lim, P Sasieni British journal of cancer 109 (1), 35-41, 2013 | 60 | 2013 |
| Risk of preterm birth following surgical treatment for cervical disease: executive summary of a recent symposium P Sasieni, A Castanon, R Landy, M Kyrgiou, H Kitchener, M Quigley, ... Bjog 123 (9), 1426, 2016 | 59 | 2016 |
| How many cervical cancers are prevented by treatment of screen‐detected disease in young women? P Sasieni, A Castanon, DM Parkin International journal of cancer 124 (2), 461-464, 2009 | 53 | 2009 |
| Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses A Castanon, M Rebolj, F Pesola, P Sasieni British Journal of Cancer 124 (8), 1361-1365, 2021 | 50 | 2021 |
| Benefits and harms of cervical screening from age 20 years compared with screening from age 25 years R Landy, H Birke, A Castanon, P Sasieni British journal of cancer 110 (7), 1841-1846, 2014 | 49 | 2014 |
| Cervical screening during the COVID-19 pandemic: optimising recovery strategies A Castanon, M Rebolj, EA Burger, IMCM de Kok, MA Smith, SJB Hanley, ... The Lancet Public Health 6 (7), e522-e527, 2021 | 43 | 2021 |
| New strategies for human papillomavirus-based cervical screening A Lorincz, A Castanon, AWW Lim, P Sasieni Women’s Health 9 (5), 443-452, 2013 | 43 | 2013 |
| Effect of diindolylmethane supplementation on low-grade cervical cytological abnormalities: double-blind, randomised, controlled trial A Castanon, A Tristram, D Mesher, N Powell, H Beer, S Ashman, G Rieck, ... British journal of cancer 106 (1), 45-52, 2012 | 43 | 2012 |
